Edwards Lifesciences (EW) Operating Margin (2016 - 2025)
Historic Operating Margin for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to 19.77%.
- Edwards Lifesciences' Operating Margin fell 61100.0% to 19.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.23%, marking a year-over-year decrease of 23300.0%. This contributed to the annual value of 25.35% for FY2024, which is 7800.0% down from last year.
- According to the latest figures from Q3 2025, Edwards Lifesciences' Operating Margin is 19.77%, which was down 61100.0% from 26.84% recorded in Q2 2025.
- Edwards Lifesciences' 5-year Operating Margin high stood at 45.99% for Q4 2022, and its period low was 19.77% during Q3 2025.
- For the 5-year period, Edwards Lifesciences' Operating Margin averaged around 29.3%, with its median value being 28.16% (2021).
- In the last 5 years, Edwards Lifesciences' Operating Margin surged by 577400bps in 2021 and then tumbled by -186000bps in 2023.
- Quarter analysis of 5 years shows Edwards Lifesciences' Operating Margin stood at 28.16% in 2021, then skyrocketed by 63bps to 45.99% in 2022, then plummeted by -40bps to 27.38% in 2023, then fell by -18bps to 22.56% in 2024, then decreased by -12bps to 19.77% in 2025.
- Its last three reported values are 19.77% in Q3 2025, 26.84% for Q2 2025, and 27.95% during Q1 2025.